ALSUntangled #73: Lion's Mane.
Amyotroph Lateral Scler Frontotemporal Degener
; 25(3-4): 420-423, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38141002
ABSTRACT
Lion's Mane (Hericium erinaceus) has historically been used as traditional medicine in Asia and Europe for its potential benefits in fighting infection and cancer. It has gained interest in the neurodegenerative disease field because of its mechanisms of action; these include anti-inflammation, neuroprotection, and promoting neurite growth demonstrated in various cell and animal models. A very small, double-blind, placebo-controlled trial in patients with mild cognitive impairment showed a temporary improvement in cognitive function; this finding has yet to be replicated. However, there have been no studies in ALS cell or animal models or in humans with ALS. Lion's Mane appears safe and inexpensive when consumed in powder or capsule, but one anaphylactic case was reported after a patient consumed fresh Lion's Mane mushroom. Currently, we do not have enough information to support the use of Lion's Mane for treating ALS. We support further research in ALS disease models and clinical trials to study its efficacy.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Neurodegenerativas
/
Agaricales
/
Esclerosis Amiotrófica Lateral
Límite:
Animals
/
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Amyotroph Lateral Scler Frontotemporal Degener
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos